<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The therapeutic results obtained in 27 patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) have been studied retrospectively </plain></SENT>
<SENT sid="1" pm="."><plain>Ten patients underwent allogenic bone marrow transplantation (BMT) and 17 received antithymocyte globulin (ATG) </plain></SENT>
<SENT sid="2" pm="."><plain>Five of the ten patients transplanted (50%) are living and show <z:mpath ids='MPATH_458'>normal</z:mpath> hemopoiesis </plain></SENT>
<SENT sid="3" pm="."><plain>Although prophylaxis was used, the incidence of <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">host-versus-graft disease</z:e> (grade II-IV) was 40% and concomitant <z:e sem="disease" ids="C0032285" disease_type="Disease or Syndrome" abbrv="PNEUM">pneumonitis</z:e> was the main cause of <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Twenty courses of ATG were given to the 17 patients </plain></SENT>
<SENT sid="5" pm="."><plain>12 responses were achieved (60%), of which two were complete and the remaining were partial </plain></SENT>
<SENT sid="6" pm="."><plain>Two patients who did not respond initially and one who recurred responded to a second course </plain></SENT>
<SENT sid="7" pm="."><plain>Eleven patients survived (64.7%) of which 10 were disease-free (58.8%) </plain></SENT>
<SENT sid="8" pm="."><plain>One of them had remission controlled with <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>The probability of long-term survival is 48% in the group transplanted and 61.6% in the group treated with ATG, showing no statistical differences </plain></SENT>
</text></document>